Pflug Koory’s Silexion Therapeutics SLXN Stock Holding History

Pflug Koory’s Portfolio SLXN Stock Details SLXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$9	Hold	33	–	–	﹤0.01%	423
2026 Q2	$84	Hold	33	–	–	﹤0.01%	425
2026 Q1	$426	Hold	33	–	–	﹤0.01%	415
2025 Q4	$639	Hold	33	–	–	﹤0.01%	408
2025 Q3	$1.13K	Buy	+33	New	+$2.74K	﹤0.01%	396

Other funds holding SLXN

WAM

Warberg Asset Management Winnetka, Illinois $755M AUM 21.42% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Pflug Koory's SLXN Position: Q3 2026 in Review

Pflug Koory held its Silexion Therapeutics (SLXN) position steady in Q3 2026 at 33 shares worth $9. The position accounts for ﹤0.01% of the portfolio, ranked #423.

Pflug Koory first reported a position in SLXN in Q3 2025 and has held it in 5 quarters since. The position peaked at $1.13K in Q3 2025. 4 funds tracked by Wall St. Rank hold SLXN as of Q3 2026.

Pflug Koory held 33 shares of Silexion Therapeutics worth $9 as of Q3 2026.
Pflug Koory left its Silexion Therapeutics share count unchanged in Q3 2026.
Silexion Therapeutics made up ﹤0.01% of Pflug Koory's portfolio in Q3 2026, its #423 holding.
Pflug Koory first reported a position in Silexion Therapeutics in Q3 2025 and has held it in 5 quarters since.
Pflug Koory's Silexion Therapeutics position peaked at $1.13K in Q3 2025.
4 funds tracked by Wall St. Rank held Silexion Therapeutics as of Q3 2026.

Based on Pflug Koory's 13F filing for Q3 2026, filed 26 Oct 2026.